Clinical Trial Update: The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular Hemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of rapamycin for treating communicating hydrocephalus caused by intraventricular hemorrhage; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Communicating Hydrocephalus
• Intraventricular Hemorrhage
• Normal Pressure Hydrocephalus
• Posthemorrhagic Hydrocephalus

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Communicating Hydrocephalus, Cerebral Intraventricular Hemorrhage | Phase 2 | Status: RECRUITING